July 26, 2023
Polypills added to WHO Essential Medicines List
Polypills, aka fixed dose combination (FDC) therapy, have been added for the first time to the 2023 Essential Medicines List...
Read MoreJuly 26, 2023
Polypills, aka fixed dose combination (FDC) therapy, have been added for the first time to the 2023 Essential Medicines List...
Read MoreJuly 6, 2023
In the most diverse study of nutrition and health outcomes in the world – and the only study with sufficient...
Read MoreJuly 4, 2023
Several PHRI researchers will present at European Society of Cardiology (ESC) Congress 2023 in Amsterdam/online next month, including an Advance...
Read MoreJuly 3, 2023
PHRI Investigator Matthew Lanktree has been awarded the 2023 Carl W. Gottschalk Research Scholar Grant from KidneyCure / American Society...
Read MoreJune 30, 2023
We are delighted to learn that hematologist Jeffrey Weitz – a long-time research collaborator with PHRI – has been named...
Read MoreJune 29, 2023
PHRI researchers provided new insights into diet and health, stroke care and outcomes, CVD care and prevention, as well as...
Read MoreBack To Top